We are happy to announce that our successful series of scientific online seminars continues. On October 08th, 2024 at 4:00PM CEST we will air our next complimentary live online seminar. The session is presented by one of Profil's Lead Scientists Dr. Hans de Vries:
Online Seminar Synopsis
Metabolic associated Fatty Liver Disease affects around 1 in five people living around the world. A small but distinct percentage develops steatohepatitis (MASH). When significant fibrosis then comes into play, risk for mortality and liver events increase. Recently the first drug for MASH received FDA approval. This also renews the interest in non-invasive diagnostic methods, which don’t require a liver biopsy. Finally, new drugs with high efficacy are in late stage of development. All this and more will be discussed during this online seminar.
Dr. Hans de Vries obtained board licenses in Internal Medicine and Endocrinology at the VU University Medical Centre, Amsterdam. He was a professor of Internal Medicine at the University of Amsterdam's Faculty of Medicine from 2016 to 2023. Having joined Profil as of 2017, he maintains his academic position for one day per week. Dr. de Vries has been Principal Investigator in numerous clinical trials and has published more than 250 peer-reviewed scientific publications. He is a frequently invited speaker at international diabetes meetings, and has been a editorial board member of Diabetes Care, the Journal of Diabetes Science and Technology, and International Associate Editor of Diabetes Technology & Therapeutics.
If you are interested in participating in this online seminar, we welcome you to register today by clicking the button below.
Also, please feel free to browse through our archive of scientific online seminars and watch our previous recordings.